Aged
C-Reactive Protein
Chronic Disease
Double-Blind Method
Female
Fluorobenzenes
Heart Failure
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Inflammation
Male
Middle Aged
Prognosis
Proportional Hazards Models
Pyrimidines
Risk Assessment
Serum Amyloid P-Component
Sulfonamides
